Americas, excluding U.S. — Total revenues
Natera, Inc. Americas, excluding U.S. — Total revenues increased by 42.0% to $2.40M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful expansion of the company's diagnostic footprint and growing adoption of its proprietary technology in international markets. A decrease may signal competitive pressure, regulatory hurdles, or reduced demand in these specific geographic regions.
Detailed definition
This metric represents the total revenue generated from diagnostic testing services and research collaborations within t...
Peer comparison
Peers in the diagnostics and life sciences sector typically report international revenue by region; this metric is comparable to 'Rest of World' or specific regional revenue segments reported by global healthcare companies.
ntra_segment_americas_excluding_u_s_total_revenuesHistorical Data
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.69M | $2.40M |
| QoQ Change | — | +42.0% |
| YoY Change | — | +42.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Natera, Inc.'s americas, excluding u.s. — total revenues?
- Natera, Inc. (NTRA) reported americas, excluding u.s. — total revenues of $2.40M in Q1 2026.
- What does americas, excluding u.s. — total revenues mean?
- Total revenue earned from customers located in the Americas, excluding the United States.